Germany · Biopharma startup

Actome

Actome focuses on developing emulsion coupling technology for life science research and personalized medicine.

Funding reportedLast round: Seed

BiopharmaFreiburg Im Breisgau, Germany

What company datasets say Actome raised

Funding, as reported

Reported in all2.5Min the source's currency
Rounds3
Last roundSeed
Last round dateDec 2022
Investors listed3

Founders and team

From Actome's own website: 5 on the team.

  • Tobias GrossChief Executive Officer
  • Maike SmitsHead of Administration
  • Marius PolletHead of Commercial Operations
  • Nina GrossHead of Production and Quality Management
  • Pablo Sanchez MartinHead of Research & Development

Biopharma in Germany

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Actome in front of investors. Or tell us what we have wrong.